These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 29894989)

  • 1. Metabolic Syndrome in Cushing's Syndrome Patients.
    Ferraù F; Korbonits M
    Front Horm Res; 2018; 49():85-103. PubMed ID: 29894989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic comorbidities in Cushing's syndrome.
    Ferraù F; Korbonits M
    Eur J Endocrinol; 2015 Oct; 173(4):M133-57. PubMed ID: 26060052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology of dyslipidemia in Cushing's syndrome.
    Arnaldi G; Scandali VM; Trementino L; Cardinaletti M; Appolloni G; Boscaro M
    Neuroendocrinology; 2010; 92 Suppl 1():86-90. PubMed ID: 20829625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose and lipid metabolism abnormalities in Cushing's syndrome.
    Salehidoost R; Korbonits M
    J Neuroendocrinol; 2022 Aug; 34(8):e13143. PubMed ID: 35980242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in adenosine 5'-monophosphate-activated protein kinase as a mechanism of visceral obesity in Cushing's syndrome.
    Kola B; Christ-Crain M; Lolli F; Arnaldi G; Giacchetti G; Boscaro M; Grossman AB; Korbonits M
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4969-73. PubMed ID: 18782871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zinc alpha-2 glycoprotein is overproduced in Cushing's syndrome.
    Escoté X; Aranda GB; Mora M; Casals G; Enseñat J; Vidal O; Esteban Y; Halperin I; Hanzu FA
    Endocrinol Diabetes Nutr; 2017 Jan; 64(1):26-33. PubMed ID: 28440767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deconstructing the roles of glucocorticoids in adipose tissue biology and the development of central obesity.
    Lee MJ; Pramyothin P; Karastergiou K; Fried SK
    Biochim Biophys Acta; 2014 Mar; 1842(3):473-81. PubMed ID: 23735216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology of diabetes mellitus in Cushing's syndrome.
    Pivonello R; De Leo M; Vitale P; Cozzolino A; Simeoli C; De Martino MC; Lombardi G; Colao A
    Neuroendocrinology; 2010; 92 Suppl 1():77-81. PubMed ID: 20829623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipose tissue in cortisol excess: What Cushing's syndrome can teach us?
    Bavaresco A; Mazzeo P; Lazzara M; Barbot M
    Biochem Pharmacol; 2024 May; 223():116137. PubMed ID: 38494065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic Alterations and Cardiovascular Outcomes of Cortisol Excess.
    Pivonello R; De Martino MC; Iacuaniello D; Simeoli C; Muscogiuri G; Carlomagno F; De Leo M; Cozzolino A; Colao A
    Front Horm Res; 2016; 46():54-65. PubMed ID: 27212264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications.
    Isidori AM; Graziadio C; Paragliola RM; Cozzolino A; Ambrogio AG; Colao A; Corsello SM; Pivonello R;
    J Hypertens; 2015 Jan; 33(1):44-60. PubMed ID: 25415766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation among body composition and metabolic regulation in a male mouse model of Cushing's syndrome.
    Uehara M; Yamazaki H; Yoshikawa N; Kuribara-Souta A; Tanaka H
    Endocr J; 2020 Jan; 67(1):21-30. PubMed ID: 31495810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
    Robaczyk MG
    Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose metabolism in Cushing's syndrome.
    Sharma A; Vella A
    Curr Opin Endocrinol Diabetes Obes; 2020 Jun; 27(3):140-145. PubMed ID: 32250974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role for sphingolipids in producing the common features of type 2 diabetes, metabolic syndrome X, and Cushing's syndrome.
    Summers SA; Nelson DH
    Diabetes; 2005 Mar; 54(3):591-602. PubMed ID: 15734832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MECHANISMS IN ENDOCRINOLOGY: Tissue-specific activation of cortisol in Cushing's syndrome.
    Morgan SA; Hassan-Smith ZK; Lavery GG
    Eur J Endocrinol; 2016 Aug; 175(2):R83-9. PubMed ID: 26957494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing's syndrome.
    Christ-Crain M; Kola B; Lolli F; Fekete C; Seboek D; Wittmann G; Feltrin D; Igreja SC; Ajodha S; Harvey-White J; Kunos G; Müller B; Pralong F; Aubert G; Arnaldi G; Giacchetti G; Boscaro M; Grossman AB; Korbonits M
    FASEB J; 2008 Jun; 22(6):1672-83. PubMed ID: 18198220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cushing's syndrome, glucocorticoids and the kidney.
    Smets P; Meyer E; Maddens B; Daminet S
    Gen Comp Endocrinol; 2010 Oct; 169(1):1-10. PubMed ID: 20655918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity and corticosteroids: 11beta-hydroxysteroid type 1 as a cause and therapeutic target in metabolic disease.
    Morton NM
    Mol Cell Endocrinol; 2010 Mar; 316(2):154-64. PubMed ID: 19804814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoid-induced Fingerprints on Visceral Adipose Tissue Transcriptome and Epigenome.
    García-Eguren G; González-Ramírez M; Vizán P; Giró O; Vega-Beyhart A; Boswell L; Mora M; Halperin I; Carmona F; Gracia M; Casals G; Squarcia M; Enseñat J; Vidal O; Di Croce L; Hanzu FA
    J Clin Endocrinol Metab; 2022 Jan; 107(1):150-166. PubMed ID: 34487152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.